RN
Ramesh Nathmal Jain
About Ramesh Nathmal Jain
Data last updated:
Ramesh Nathmal Jain is a Director at Arizzer Pharmaceuticals Private Limited (since 2022). The company operates in Pharma. Arizzer Pharmaceuticals Private Limited reported revenue of ₹2.11 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Arizzer Pharmaceuticals Private Limited U51909MH2022PTC380228 | Director | 09 Apr 2022 | 2022 | ₹2.11 Cr (FY 2024) | Active |
Board colleagues of Ramesh Nathmal Jain
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kavita Jain | 09566766 | Arizzer Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ramesh Nathmal Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ramesh Nathmal Jain
Ramesh Nathmal Jain currently holds 1 directorship: Arizzer Pharmaceuticals Private Limited (Director, since 09 Apr 2022, revenue ₹2.11 Cr (FY 2024)).
Ramesh Nathmal Jain was first appointed on 09 Apr 2022 as Director at Arizzer Pharmaceuticals Private Limited.
The current boards of Ramesh Nathmal Jain's companies include Kavita Jain (Arizzer Pharmaceuticals Private Limited).